BUSINESS

Intellia Therapeutics, Inc. (NTLA) Sees Moderate Buy Rating From Analysts

Apr 23, 2026 - 11:00
Intellia Therapeutics, Inc. (NTLA) Sees Moderate Buy Rating From Analysts
Read More

Tags:

Previous Article

Iran War Has Cost The World $50 Billion of Lost Oil Supply, So Far

Next Article

American International Group Earnings Preview: What to Expect

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Obesity Drugs Covered In Medicare Change. Questions Remain For Lilly, Novo.

Obesity Drugs Covered In Medicare Change. Questions Rem...

Apr 22, 2026

LXP (LXP) Q3 2025 Earnings Transcript

LXP (LXP) Q3 2025 Earnings Transcript

Apr 23, 2026

AI Data Center Boom Supercharges GE Vernova Earnings. This Is How Much.

AI Data Center Boom Supercharges GE Vernova Earnings. T...

Apr 22, 2026